Refine Results
- Products
- Applications and Industries
-
- Content Type
-
Content Type
- Analysis Platform
-
Product
- Language
-
Language
Applied Filters
The Agilent xCELLigence real-time cell analysis (RTCA) eSight system gives its users the flexibility to use both label-free impedance and/or imaging in four channels for the real-time monitoring of cell proliferation and cytotoxicity. The eSight has...
- Publication Part Number: 5994-8429EN
- Created: 22 Sep 2025
- 2 MB
Here we describe image-based immune cell killing assays of 3D single tumor spheroids expressing RFP using the xCELLigence RTCA eSight.
- Publication Part Number: 5994-8380EN
- Created: 14 July 2025
- 2 MB
Recently updated Cancer Immunotherapy Handbook featuring the latest high impact xCELLigence publications and newly released supporting information.
- Publication Part Number: 5994-1303EN
- Created: 08 July 2025
- 6 MB
Describes use of a tethering approach to immobilize liquid tumor cell lines on to the surface of gold biosensors embedded in an Agilent E-Plate.
- Publication Part Number: 5994-1066EN
- Created: 27 June 2025
- 687 KB
This application note demonstrates a robust method for performing real-time antibody internalization assays using the Agilent xCELLigence RTCA eSight combined with CypHer5E pH-sensitive dyes.
- Publication Part Number: 5994-8106EN
- Created: 02 May 2025
- 4 MB
CAR T-cell manufacturing conditions are critical to differentiation, metabolic fitness, and cytotoxic function, enhancing therapy efficacy and production efficiency.
- Publication Part Number: Cyto 2025
- Created: 05 June 2025
- 537 KB
Poster presented at AAI 2025. Immune cell-mediated cytotoxicity of CD19 CAR-T cells against Raji suspension tumor cells was monitored and measured using real-time whole-well live cellimaging on the xCELLigence RTCA eSight system with its 5x...
- Publication Part Number: AAI 2025 #3083
- Created: 14 May 2025
- 3 MB
In this study, we present a robust approach to monitor and analyze the bystander effect of Antibody-Drug Conjugates in real-time using live-cell imaging andimpedance measurements with the Agilent xCELLigence RTCA eSight system.
- Publication Part Number: AACR 2025 #5476
- Created: 25 Apr 2025
- 2 MB
AACR 2025 poster: Chronic anti-CD3/CD28 stimulation during cell expansion generates exhausted T cells with a distinct metabolic and cytotoxic phenotype
- Publication Part Number: AACR #4856
- Created: 25 Apr 2025
- 475 KB
This poster aims to demonstrate the capability of impedancebased xCELLigence RTCA assays for virus and antibody titer, as well as for identification and characterization of antiviral drugs.
- Created: 25 Apr 2025
- 930 KB
The poster introduces a multiparametric workflow that allows for evaluating contractility, viability, and metabolic function using validated human iPSC-derived cardiomyocytes to better understand the mechanisms associated with drug-induced...
- Publication Part Number: SOT # 4373
- Created: 24 Mar 2025
- 504 KB
There is a need for functional potency assays that can be used to rapidly test the efficacy of different immunotherapy approaches, including but not limited tosmall molecules, biologics, cell therapies, or combinations of these agents
- Publication Part Number: #91
- Created: 19 Mar 2025
- 2 MB
The eSight can be used to study cytotoxicity kinetics of lymphocytes invading a deregulated extracellular matrix present in solid tumors.
- Created: 19 Mar 2025
- 2 MB
This quick reference guide provides detailed instructions on how to prepare, perform, and evaluate the impedance-based TCID50 protocol using the xCELLigence RTCA Software Pro Virology module to determine viral titer
- Publication Part Number: 5994-7860EN
- Created: 18 Mar 2025
- 143 KB
we demonstrated consistent production of CAR T-cells using the functionally closed and automated cell manufacturing Lonza Cocoon platform, using a novelcombination of cell analysis parameters obtained from an Agilent xCELLigence RTCA system, a...
- Publication Part Number: #149
- Created: 17 Mar 2025
- 375 KB
The invasion of the 3D spheroid in the presence or absence of drug treatment was monitored and quantified using the brightfield and fluorescence live cell time-lapse
- Created: 17 Mar 2025
- 371 KB